Sanara MedTech Inc. (SMTI) stock
SMTINasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30144% above fair value
$32.67−0.06 (-0.18%)
Close on Nov 19, 2026Market cap $300.17MP/E –Yield –
Sanara MedTech revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Sanara MedTech's revenue for the twelve months ending Jun 30, 2026 was $109.81M, up 13.0% year over year. For fiscal 2025 it was $103.12M, up 19.0% from the year before. Over ten years it grew 40.8% a year on average. The highest annual figure on record is $103.12M in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $103.12M | +19.0% |
| FY2024 | Dec 31, 2024 | $86.67M | +33.4% |
| FY2023 | Dec 31, 2023 | $64.99M | +41.8% |
| FY2022 | Dec 31, 2022 | $45.84M | +89.9% |
| FY2021 | Dec 31, 2021 | $24.14M | +54.9% |
| FY2020 | Dec 31, 2020 | $15.59M | +32.5% |
| FY2019 | Dec 31, 2019 | $11.77M | +101.6% |
| FY2018 | Dec 31, 2018 | $5.84M | -7.4% |
| FY2017 | Dec 31, 2017 | $6.30M | +14.5% |
| FY2016 | Dec 31, 2016 | $5.51M | +63.3% |
| FY2015 | Dec 31, 2015 | $3.37M | +28.1% |
| FY2014 | Dec 31, 2014 | $2.63M | +52.5% |
| FY2013 | Dec 31, 2013 | $1.73M | +47.1% |
| FY2012 | Dec 31, 2012 | $1.17M | -46.9% |
| FY2011 | Dec 31, 2011 | $2.21M | +142.7% |
| FY2010 | Dec 31, 2010 | $910.42K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $28.14M | +9.0% |
| Q1 FY2026 | Mar 31, 2026 | $27.80M | +18.6% |
| Q4 FY2025 | Dec 31, 2025 | $27.55M | +4.7% |
| Q3 FY2025 | Sep 30, 2025 | $26.33M | +21.5% |
| Q2 FY2025 | Jun 30, 2025 | $25.80M | +28.0% |
| Q1 FY2025 | Mar 31, 2025 | $23.43M | +26.4% |
| Q4 FY2024 | Dec 31, 2024 | $26.31M | +48.7% |
| Q3 FY2024 | Sep 30, 2024 | $21.67M | +35.2% |
| Q2 FY2024 | Jun 30, 2024 | $20.16M | +28.0% |
| Q1 FY2024 | Mar 31, 2024 | $18.54M | +19.4% |
| Q4 FY2023 | Dec 31, 2023 | $17.69M | +15.5% |
| Q3 FY2023 | Sep 30, 2023 | $16.02M | +22.8% |
| Q2 FY2023 | Jun 30, 2023 | $15.75M | +62.9% |
| Q1 FY2023 | Mar 31, 2023 | $15.52M | +98.7% |
| Q4 FY2022 | Dec 31, 2022 | $15.32M | +117.8% |
| Q3 FY2022 | Sep 30, 2022 | $13.04M | +124.0% |
| Q2 FY2022 | Jun 30, 2022 | $9.67M | +54.1% |
| Q1 FY2022 | Mar 31, 2022 | $7.81M | +55.9% |
| Q4 FY2021 | Dec 31, 2021 | $7.03M | +46.9% |
| Q3 FY2021 | Sep 30, 2021 | $5.82M | +35.2% |
| Q2 FY2021 | Jun 30, 2021 | $6.28M | +111.6% |
| Q1 FY2021 | Mar 31, 2021 | $5.01M | -22.8% |
| Q4 FY2020 | Dec 31, 2020 | $4.79M | +42.8% |
| Q3 FY2020 | Sep 30, 2020 | $4.31M | +48.0% |
| Q2 FY2020 | Jun 30, 2020 | $2.97M | -1.7% |
| Q1 FY2020 | Mar 31, 2020 | $6.49M | +161.0% |
| Q4 FY2019 | Dec 31, 2019 | $3.35M | +6953.7% |
| Q3 FY2019 | Sep 30, 2019 | $2.91M | +85.7% |
| Q2 FY2019 | Jun 30, 2019 | $3.02M | +33.4% |
| Q1 FY2019 | Mar 31, 2019 | $2.49M | +26.8% |
| Q4 FY2018 | Dec 31, 2018 | $47.54K | -97.2% |
| Q3 FY2018 | Sep 30, 2018 | $1.57M | +1.1% |
| Q2 FY2018 | Jun 30, 2018 | $2.26M | +55.7% |
| Q1 FY2018 | Mar 31, 2018 | $1.96M | +22.2% |
| Q4 FY2017 | Dec 31, 2017 | $1.70M | -2.7% |
| Q3 FY2017 | Sep 30, 2017 | $1.55M | +9.9% |
| Q2 FY2017 | Jun 30, 2017 | $1.45M | – |
| Q1 FY2017 | Mar 31, 2017 | $1.61M | – |
| Q4 FY2016 | Dec 31, 2016 | $1.75M | – |
| Q3 FY2016 | Sep 30, 2016 | $1.41M | – |
See a number that looks wrong?